These are vaccines from CanSino Biologics and the Wuhan Institute for Biologicals, in particular from covid-19.
State Administration of Pharmaceutical Control of the People's Republic of China approves covid-19 vaccines, from CanSino Biologics and Wuhan Biologicals Institute for general use.
Subsidiary of China State Biotechnology Group (CNBG), controlled by Sinopharm, 21 February applied for conditional market entry of its inactivated vaccine.
Both Chinese Vaccines Reach Phase Three Clinical Trials, their research was carried out in different countries of the world. According to intermediate test data, published yesterday by the Wuhan Institute of Biologicals, then covid-19 vaccines are effective in 72,51% cases.
According to the Prime Minister of Health of Pakistan Faisal Sultan, CanSino Biologics is effective in 65,7% cases to prevent clinical symptoms and 90,98% to prevent severe cases of COVID-19.
Previously, the Chinese authorities approved vaccines Sinopharm and Sinovac Biotech for wide use. At the same time, developers continue to research and report their findings to supervisory authorities..
- We also recommend reading the article, MIS-C syndrome associated with Covid-19 in children.
- The article was taken and published from open media sources
with text tass.ru support.
Coronavirus breaking news today (Saturday - 17.04.2021 year)
More details ...